SEMENTIS Trademark

Trademark Overview

On Tuesday, February 11, 2014, a trademark application was filed for SEMENTIS with the United States Patent and Trademark Office. The USPTO has given the SEMENTIS trademark a serial number of 79145730. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, February 12, 2024. This trademark is owned by Sementis Limited. The SEMENTIS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment and prevention of viral and infectious diseases, cancer, allergies and immune disorders; pharmaceutical substances for the treatment and prevention of viral and infectious diseases, cancer, allergies and immune disorders; pharmaceutical products for the treatment and prevention of viral and infectious diseases, cancer, allergies and immune disorders; biological preparations for the treatment and prevention of viral and infectious diseases, cancer, allergies and immune disorders; biological substances for the treatment and prevention of viral and infectious diseases, cancer, allergies and immune disorders; vaccines; diagnostic preparations and reagents for medical purposes

Research and development relating to pharmaceuticals; biological research; testing and clinical trials of pharmaceuticals and biological substances; services for assessing the efficiency of pharmaceuticals and biological substances, namely, conducting evaluations of new pharmaceutical products; services for assessing the safety of pharmaceuticals and biological substances, namely, product safety testing
sementis

General Information

Serial Number79145730
Word MarkSEMENTIS
Filing DateTuesday, February 11, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, February 12, 2024
Registration Number4725775
Registration DateTuesday, April 28, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 10, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of viral and infectious diseases, cancer, allergies and immune disorders; pharmaceutical substances for the treatment and prevention of viral and infectious diseases, cancer, allergies and immune disorders; pharmaceutical products for the treatment and prevention of viral and infectious diseases, cancer, allergies and immune disorders; biological preparations for the treatment and prevention of viral and infectious diseases, cancer, allergies and immune disorders; biological substances for the treatment and prevention of viral and infectious diseases, cancer, allergies and immune disorders; vaccines; diagnostic preparations and reagents for medical purposes
Goods and ServicesResearch and development relating to pharmaceuticals; biological research; testing and clinical trials of pharmaceuticals and biological substances; services for assessing the efficiency of pharmaceuticals and biological substances, namely, conducting evaluations of new pharmaceutical products; services for assessing the safety of pharmaceuticals and biological substances, namely, product safety testing

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateMonday, December 5, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateMonday, December 5, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSementis Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressHACKNEY 5069
AU
Party NameSementis Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU
Party NameSementis Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events

Event DateEvent Description
Tuesday, April 29, 2014APPLICATION FILING RECEIPT MAILED
Thursday, April 24, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 25, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 19, 2014ASSIGNED TO EXAMINER
Friday, May 23, 2014NON-FINAL ACTION WRITTEN
Saturday, May 24, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, May 27, 2014REFUSAL PROCESSED BY MPU
Tuesday, May 27, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, June 13, 2014REFUSAL PROCESSED BY IB
Wednesday, November 26, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 28, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 26, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 26, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 2, 2014ASSIGNED TO LIE
Tuesday, December 9, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 9, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, December 27, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 30, 2014ASSIGNED TO LIE
Saturday, January 3, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 21, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 21, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 21, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, January 26, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 6, 2015NOTIFICATION PROCESSED BY IB
Tuesday, February 10, 2015PUBLISHED FOR OPPOSITION
Tuesday, February 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 28, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, July 28, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, August 26, 2015FINAL DISPOSITION PROCESSED
Wednesday, August 26, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 11, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, March 25, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 25, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 5, 2018NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, April 28, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, April 6, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 6, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 6, 2021TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Tuesday, April 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 6, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 16, 2021TEAS SECTION 71 RECEIVED
Thursday, September 2, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 12, 2021POST REGISTRATION ACTION MAILED - SEC.71
Tuesday, April 12, 2022TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, April 28, 2022POST REGISTRATION ACTION MAILED - SEC.71
Monday, December 5, 2022CANCELLED SECTION 71
Tuesday, December 6, 2022NOTICE OF CANCELLATION SEC. 71 E-MAILED
Saturday, August 5, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, September 25, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Sunday, September 3, 2023INVALIDATION PROCESSED
Sunday, September 3, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, August 31, 2024DEATH OF INTERNATIONAL REGISTRATION
Saturday, August 31, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, December 16, 2023NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

sementis biological cancer immune substances diseases disorders allergies infectious treatment prevention